Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Solcogyn
- Development stage
- Unknown
- Lead developer
- Department of Health
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Solcogyn is a topical chemical solution used for the local treatment of cervical ectopy and low-grade cervical intraepithelial neoplasia (CIN). It is a caustic agent composed of a combination of acids, including nitric acid, acetic acid, and oxalic acid, along with zinc nitrate. The preparation is applied directly to the cervix ("paint-on") to chemically ablate abnormal tissue. It has been evaluated in clinical trials, including an open-label placebo-controlled trial sponsored by the UK Department of Health, and has been compared to cryotherapy for cervical ectopia. It is considered a niche or investigational product in Western markets.
- Brand names
- Solcogyn
- Other names
- Solcogyn solution
Beyond the preview
Go deeper on Solcogyn.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solcogyn.